<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Neuro Therapies

Complete coverage of the neuromodulation and neurovascular markets.

 

Request a Demo

 

The top neuro therapy companies depend on SmartTRAK!

We provide up-to-date intel on trends, news, financial data, and competitor developments. Our team of analysts is experts in their field - all with previous industry experience. We have our finger on the pulse to bring you the most relevant, accurate data, analyses, and intelligence so that you can make better, more informed strategic business decisions.

1 Analyst

2 Modules

33 Companies

55 Products

Direct Access

to our analysts when you need them.

Daily Updates

on the latest news, earnings calls, studies, patent filings, new products and more!

Analysis and Insights

featuring Quarterly Market Recaps, Interviews, Conferences and more!

Oct-11-2019 Insera Therapeutics’ co-founders and brothers Vikram Janardhan and Vallabh Janardhan, MD saw an opportunity in the market for acute ischemic stroke and have developed a next-generation, all-digital vacuum aspiration system for mechanical thrombectomy designed to take suction aspiration to a new level.
Anne Staylor
ANNE STAYLOR
SmartTRAK Managing Editor, Business Intelligence and Senior Director, Advanced Technologies
Q219 SCS MARKET RECAP: In Q219, US and WW spinal cord stimulation (SCS) revenues were down for all the big players against tough YoY comps and ongoing weakness in the market as companies work through a gap in new product introductions, ongoing commercial execution issues and customer destocking. In the US, SCS revenues were down -6.3% vs Q218 according to the SmartTRAK Financial Dashboard.
Anne_DSC_7315c 400x400
Anne Staylor
SmartTRAK Managing Editor, Business Intelligence and Senior Director, Advanced Technologies
 

Neuro Therapies Modules

MODULE DETAILS

Neurovascular - US

PDevices for the treatment of Acute Ischemic Stroke (AIS) from clots or masses cutting off blood flow to part of the brain.

  • Mechanical Thrombectomy

Neuromodulation - US

Devices for the modulation of chronic, intractable, neuropathic pain.

  • Spinal Cord Stimulators

 

New call-to-action

 

Analysis

Written by our team of experts, SmartTRAK analysis features real-time articles, videos, and interviews with subject matter experts. Learn about up-and-coming neuromodulation and neurovascular companies or about the latest products to hit the market.  Our analysts also keep you up-to-date on the latest market trends and competitive news with quarterly market recaps, market overviews and more. 

 

Neuro Markets

SmartTRAK profiles both the neurovascular and neuromodulation markets in real-time.  Easily find market dollars, 5-year projections,  incidence & prevalence, reimbursement, and relevant news and market happenings for all competitors within the space.

Download Modules & Segments PDF

 

Company Profiles

Each company profile features a quick overview along with information on revenues & financial outlook, financing, acquisitions, and strategic alliances.  Perfect for competitive analysis or M&A research.

 

 

Product Profiles

Product Profiles are robust and give an in-depth look at a particular product. Each profile includes a brief product description and the most current information on clinical studies, regulatory approvals, sales and more. Product profiles are an important tool for many SmartTRAK users.

 

Product Explorer Tool

Product Explorer Tool enables you to quickly drill down on the neuro therapies market by segment, indication, regulatory status and more giving you an up-to-date view of the global competitive landscape in seconds.

 

Financial Dashboard Tool

Easily size a market, gauge market share, compare year over year growth and quickly spot trends. Users can sort data by market, segment, sub-segment, and more and can easily get the financial data they need.

 

Gap Analysis Tool

Quickly visualize your portfolio in seconds! Users can quickly see gaps in their own offering and identify acquisition targets that could potentially strengthen their offering.